correlation between cell marker proteins and transporter proteins was evaluated to choose the best EC marker protein for protein quantification normalization. The membrane protein Pecam-1 showed a very high correlation with the EC-specific transporter P-gp (Pearson product-moment correlation coefficient (r) > 0.89) and moderate to high with Bcrp (r ≥ 0.77), that can be found also in pericytes and astrocytes. Therefore, Pecam-1 was selected as a marker for the normalization of the quantification of the proteins of endothelial cells.
Abstract
Liquid chromatography coupled to tandem mass spectrometry-based targeted absolute protein quantification (in fmol of the analyte protein per lg of total protein) is employed for the molecular characterization of the blood-brain barrier using isolated brain microvessels. Nevertheless, the heterogeneity of the sample regarding the levels of different cells co-isolated within the microvessels and bovine serum albumin (BSA) contamination (from buffers) are not always evaluated. We developed an unlabeled targeted liquid chromatography coupled to tandem mass spectrometry method to survey the levels of endothelial cells (ECs), astrocytes, and pericytes, as well as BSA contaminant in rat cortical microvessels. Peptide peak identities were evaluated using a spectral library and chromatographic parameters. Sprague-Dawley rat microvessels obtained on three different days were analyzed with this method complemented by an absolute quantification multiple reaction monitoring method for transporter proteins P-gp, Bcrp, and Na + /K + ATPase pump using stable isotope labeled peptides as internal standard. Inter-day differences in the cell markers and BSA contamination were observed. Levels of cell markers correlated positively between each other. Then, the
The microvascular endothelium in the brain acts as a physical and biochemical barrier known as the blood-brain barrier (BBB), which helps to maintain the homeostasis in the parenchyma. The exchange of endogenous and exogenous (e.g., drugs) molecules between the brain and the bloodstream through endothelial cells is regulated by a series of mechanisms, including a limited passive diffusion of molecules, influx and efflux transporter proteins and channels, adsorption or receptor-induced transcytosis, and drugmetabolizing enzymes (Abbott et al. 2010) . Therefore, molecular characterization of the endothelial cells (ECs) is important to better understand the involvement of the BBB in neuropharmacology under physiopathological situations. Targeted liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is thus used for the absolute quantification of membrane proteins, such as ATP-binding cassette (ABC) and solute carrier transporters (Kamiie et al. 2008; Hoshi et al. 2013; Chaves et al. 2016 ). Brain microvessels can be dissociated from parenchymal cells for their isolation employing either a mechanical homogenization using a Potter-Elvehjem homogenizer (Yousif et al. 2007; Boulay et al. 2015) or an enzymatic dissociation (Bowman et al. 1981) . Through the mechanical procedure, the obtained sample contains, in addition to the ECs, also the associated cells such as pericytes, cell membranes of astrocyte feet, neuronal processes, and even oligodendrocytes. These cells are strongly attached to the ECs and constitute a functional structure known as the neurovascular unit (Pardridge 1999; Abbott et al. 2010; Boulay et al. 2015) .
It is well known that contaminant proteins in samples can importantly reduce the number of protein identifications in shotgun analysis (Hodge et al. 2013) . In targeted absolute proteomics, specific protein levels are often reported as number of molecule per unit of total proteins in the sample (e.g., fmol per lg). Therefore, when total proteins of brain microvessels are quantified, a different degree of bovine serum albumin (BSA) contamination or the presence of proteins from other cells can induce a bias in the results and data interpretation. It is thus important to control the level of EC enrichment in the sample.
Several phenotypic EC biomarkers of well differentiated brain endothelium were used to control for the level of EC enrichment in isolated rodent and human brain microvessels by mechanical procedures, such as transporters for nutrients (glucose transporter GLUT-1), Flt-1 vascular endothelial growth factor (VEGF) receptor, von Willebrand factor, gamma-glutamyl transpeptidase, and adhesion molecules such as platelet endothelial cell adhesion molecule (PECAM 1/CD31) and intercellular adhesion molecule (ICAM) (Yousif et al. 2007; Shawahna et al. 2011; Uchida et al. 2011; Boulay et al. 2015) .
In this study, we first highlighted the heterogeneity of the microvessels extracted by a mechanical isolation. We detected specific markers of ECs, astrocytes, and pericytes, using a LC-MS/MS (targeted multiple reaction monitoring, MRM) method and showed a high variability in the absolute concentrations of P-gp, Bcrp, and ATPase isoforms. Furthermore, we evaluated the correlation between the levels of these markers and those of endothelial cells to select the best fitting EC marker for the normalization of absolute concentration of proteins expressed by the endothelial cells. This methodology can be applied during comparative analyses.
Material and methods
Materials HPLC-grade acetonitrile and methanol were purchased from Merck (Nogent-sur-Marne, France) and chloroform (HiPerSolv, Chromanorm for HPLC) from VWR (Strasbourg, France). HPLC-grade formic acid (99% w/w) was supplied by Fischer Scientific (Illkirch, France). All Fmoc-protected amino acids, pre-loaded Wang resin, and peptide synthesis reagents were purchased from Novabiochem â (Merck Millipore, Darmstadt, Germany).
15
N and 13 C labeled Fmoc-protected amino acids and triisopropylsilane were from Sigma-Aldrich. Trifluoroacetic acid (TFA), piperidine, and N,Ndimethylformamide (DMF) for peptide synthesis were from Carlo Erba Reagents (Val de Reuil, France).
Bicinchoninic acid Protein Assay Kit, Hank's balanced salt solution, and HEPES buffer were purchased from Thermo Scientific (Illkirch, France). The following reagents were acquired from Sigma-Aldrich (Saint Quentin Fallavier, France): NaCl, MgCl 2 , KCl, ethylenediaminetetraacetic acid, Tris-HCl, sucrose, GuanidineHCl, dithiothreitol, iodoacetamide, BSA, dextran (molecular weight 70 000), and urea. The Protease Inhibitor Cocktail cOmplete Mini â was provided by Roche (Bâle, Switzerland). Sequencing grade Modified Trypsin, Mass Spectrometry grade rLys-C, and Protease-MAX surfactant were acquired from Promega (Charbonni eres-lesBains, France). The synthetic E. coli peptides (Hi3 Ecoli â standards) used for controlling the liquid chromatography performance were purchased from Waters (Guyancourt, France). Radioimmunoprecipitation assay (RIPA) buffer was prepared with analytical grade reagents from Sigma-Aldrich: 150 mmol/L NaCl, 50 mmol/L Tris (pH 8.0), 1% (V/V) Triton X-100, 0.5% (W/V) sodium deoxycholate, and 0.1% (V/V) sodium dodecyl sulfate in water. Standard peptides for protein quantification were either purchased from Pepscan (Lelystad, The Netherlands) or synthetized in home in solid phase, using Fmoc chemistry.
Peptide synthesis
A microwave assisted CEM-Liberty 1 synthesizer was used with Pepdrive software (CEM lWave SAS, Saclay, France) for the peptide synthesis. Beginning with Fmoc-amino acid pre-loaded Wang resin (0.1 mmol, 0.6 mmol/g), the coupling was achieved by diisopropylcarbodiimide/Oxymapure â in DMF and Fmoc deprotection by 20% (V/V) piperidine and 0.1 mol/L Oxymapure â in DMF.
Peptides were released from the resin with a 10 mL solution of TFA containing 2.5% water and 2.5% triisopropylsilane (V/V), removing the side chain protections simultaneously. Then, the resin was filtered off; the filtrate was concentrated and precipitated in cold diethyl ester and collected by centrifugation. Purification was performed using a Shimadzu semi-preparative HPLC system using a GRACE Vydac Protein and Peptide 218TP column (10 9 250 mm) and then analyzed on a Shimadzu Prominence LC-20AD HPLC with a GRACE Vydac Protein and Peptide 218TP column (4.6 9 250 mm) in a linear gradient consisting of a mixture of (A) 0.1% TFA in water (V/V) and (B) 0.09% TFA in 70% acetonitrile and 30% water (V/V). The flow rate was of 2 mL/min for purification and 1 mL/min for analysis. The molecular weight of peptides was controlled by matrix-assisted laser desorption/ionization -time of flight (MALDI-TOF) and the concentration in standard solutions was determined by amino acid analysis (AAA) of the hydrolyzed peptides (6 mol/L hydrochloric acid for 24 h at 110°C).
Biological samples
Adult male Sprague-Dawley rats (RRID: RGD_70508) weighing 200-250 g (5-7 weeks old) were purchased from Janvier laboratory (Le Genest-Saint-Isle, France). They were housed in a temperatureand humidity-controlled room under standard 12 h light/dark conditions in groups of three animals per cage. Animals were acclimated for a minimum of 7 days prior to conducting experiments. Food and water were provided ad libitum. All the animal experiments complied with the standards and guidelines promulgated by the latest European Union Council Directive (2010/63/EU). The choice of rats was randomized daily using the Excel RANDBETWEEN function to assign the rats into groups. For ethical reasons, the sample size was limited to 12 animals.
Isolation of rat brain cortical microvessels Microvessels were isolated from rat brain cortex as previously described (Yousif et al. 2007; Chaves et al. 2016) , maintaining samples at 4°C during the whole procedure. Rats were killed by CO 2 inhalation and decapitated. Brain cortices were dissected, then transferred to a Becker containing buffer 1 (Hank's balanced salt solution supplemented with 10% (V/V) HEPES), minced using scalpels and homogenized using a Potter-Elvehjem homogenizer (Kontes Glass, Vineland, NJ, USA). Samples were centrifuged in buffer 1 containing 17.5% (W/V) dextran (64-76 kDa, buffer 2) and filtered through two successive nylon meshes (100 and 20 lm). The vessels retained in the 20 lm mesh were recovered in buffer 1 containing 1% (W/V) BSA (buffer 3) and washed twice with buffer 1 (BSA-free). Proteins were extracted with RIPA buffer, aided by ultrasounds homogenization using a BioRuptor (Diagenode, Seraing (Ougr ee), Belgium) in high mode for 5 min. The lysate was centrifuged 15 min at 10 000 g and the supernatant was recovered. Rat microvessels isolation was performed in three different days; on each day, eight rats were killed and fresh brain cortices were pooled by two before homogenizing and microvessels isolation, obtaining thus four samples per day.
Protein digestion
Protein samples were digested as previously reported (Chaves et al. 2016) . Briefly, denatured and alkylated proteins were precipitated using a methanol-chloroform-water system, resuspended using urea and Protease-Max detergent in Tris-HCl buffer (pH 8.5) and digested in tandem using Lys-C and Trypsin endoproteases. Stable isotope labeled (SIL) peptides for P-gp, Bcrp, and Na + /K + ATPase were added after digestion for absolute quantification. Samples were dried using a centrifugal vacuum concentrator (Maxi-Dry Lyo; Heto Lab Equipment, Allerod, Denmark), stored at À80°C and solubilized just before analysis in a mixture of 10% acetonitrile, 90% water plus 0.1% formic acid, including 100 fmol/lL of six synthetic E. coli control peptides that were used to evaluate the reproducibility of LC-MS/MS analysis of peptides (Hi3 Ecoli â standards; Waters).
An external protein was added to the samples before the treatment to control its reproducibility (Gomez-Zepeda et al. 2016) .
DDA shotgun proteomics analysis and data treatment NanoLC-MS/MS data-dependent acquisition was performed using a Dionex Ultimate 3000 Rapid Separation LC nano system coupled to a Q-Exactive Plus Orbitrap (Thermo Scientific). The chromatographic solvents were 0.1% (V/V) formic acid in water (A) and 80% acetonitrile, 0.08% formic acid (V/V) (B). Peptides were vacuumdried, then resuspended in a mixture of 90% water, 10% acetonitrile plus 0.1% trifluoroacetic acid (V/V). The equivalent to 1 lg of peptides was injected into the system and separated on a 50 cm reversed-phase liquid chromatographic column (Pepmap C18; Thermo Scientific) using a gradient of 5% to 40% B in 120 min, followed by 10 min increasing from 40% to 80% B. After 11 min of 80% B (t = 131 min), the gradient returned to 5% B to reequilibrate the column. The mass spectrometer was configured to acquire the MS/MS spectra using a top-10 data-dependent acquisition (DDA) with dynamic exclusion set to 30 s. The MS scan range was from 400 to 2000 m/z. Resolution was set to 70 000 for MS scans and 17 500 for MS/MS scans to increase acquisition speed. The MS Automatic Gain Control target was set to 3.10 6 counts, while MS/MS Automatic Gain Control target was set to 1.10 5 . NanoLC-MS/MS data treatment was performed with Proteome Discoverer v1.4 (Thermo Scientific) using the Mascot search engine (version 2.2.07; Matrix Science, London, UK) for protein identification against the rat UniProt database (The UniProt Consortium 2014) (release 2016.02, 29 974 entries), including bovine serum albumin (BSA, UniProt entry: P02769). Oxidation (Met) was set as variable modification, whereas Carbamidomethylation (Cys) was set as fixed modification. One possible misscleavage was allowed. The enzyme used was trypsin, monoisotopic peptide mass tolerance was set at AE 10 ppm and fragment mass tolerance was AE 0.02 Da. Only ions with score superior to 25 were considered. Peptide false discovery rates were calculated from a decoy database using the percolator function of Proteome Discoverer. Data were filtered to a false discovery rate of 1%. A spectral library was created in Skyline (MacLean et al. 2010) using the identification results from the peptide search with a cut-off score of 0.99 (percolator false discovery rate = 1%) (MSF file) for verification of peptide peak identities in the MRM analyses. The protein list obtained was analyzed using DAVID bioinformatics tool (Huang et al. 2009a,b) for GO cellular component (CC3) annotation to verify the representation of plasma membrane proteins.
MRM assay development, and data treatment Candidate proteotypic peptides for BSA and cell marker proteins of ECs, pericytes, and astrocytes were selected from the list of sequences identified in DDA experiment by applying previously reported criteria for their stability, compatibility for triple-quadrupole detection, and protein specificity (Kamiie et al. 2008; Ludwig and Aebersold 2014) . Neuron and oligodendrocyte markers were not included as these are found in very low proportion in isolated microssevels (Pardridge 1999) . Specificity of each peptide was verified using the Protein Information Resource peptide search (http://pir.georgetown.edu) (Wu et al. 2003) . BSA proteotypic peptides were selected so that they were not present in any protein from the rat proteome. The peptides for the quantification of P-gp, Bcrp, and Na + /K + ATPase have been previously reported (Kamiie et al. 2008) and are presented in Table S1 . The digested protein samples of rat brain cortical microvessels from the three different days were analyzed using a scheduled MRM method. The samples were injected in a random order using the RANDBETWEEN function of Excel. The inter-injection reproducibility was evaluated by including the Hi3 Ecoli â standard peptide mix in the solution used for suspending the peptides before analysis.
Absolute quantification of P-gp, Bcrp, and Na + /K + ATPase was performed using the absolute quantification of proteins using SIL peptides approach (Kirkpatrick et al. 2005) . Proteotypic peptides were synthetized in light and heavy (SIL) forms as standards. A dilution curve including the light peptides covering a range from 0.125 to 125 fmol/lL and the heavy peptides in constant concentration (15 fmol/lL) was analyzed in triplicate. The QuaSAR plugin (Mani et al. 2012) for Skyline was used to obtain the limit of detection (LOD) and limit of quantification (LOQ) as well as the linear regression equation for each transition using the light-toheavy peak area ratio. Peptide amounts were calculated, using an Rscript, as the mean of the concentration of three or four transitions obtained using the linear equations and transformed to fmol per lg of total protein in the sample. Unlabeled MRM method for the analysis of cell markers and BSA was refined by performing a first screening using unscheduled analysis to search for the candidate proteotypic peptides in digests from rat microvessel protein samples and pure BSA. Chromatograms were manually inspected using Skyline in order to verify peak identity in function of the following parameters: (i) coelution of at least three transitions; (ii) the correlation between the relative intensities of the transitions detected in the sample and the library built using the DDA results, calculated as a dotproduct correlation by Skyline (De Graaf et al. 2011) ; (iii) the proximity to the predicted retention time (RT), calculated by the Skyline's built-in SSRCalc 3.0 algorithm (Krokhin 2006 ) from a regression curve obtained using the heavy peptides spiked into the samples (n = 11, Figure S1 ), and (iv) the signal intensity and the absence of interferences for at least three transitions. The selected peptides were included into the scheduled MRM method used for protein quantification in the following assays (Table S2) .
The BSA concentration in samples was determined using the unlabeled Hi3 quantification method (Silva et al. 2006; Zauber et al. 2013; Wang and Hanash 2015) .
Targeted LC-MS/MS analyses were performed on an ACQUITY UPLC H-Class â System on line with a Waters Xevo â TQ-S mass spectrometer (Waters, Manchester, UK). Peptides were injected into an ACQUITY UPLC BEH â C18 column (Peptide BEH â C18
Column, 300 A, 1.7 lm, 2.1 9 100 mm; Guyancourt, France) and eluted over a 24 min gradient where the mobile phase consisted in a mixture of water and acetonitrile [formic acid 0.1% (V/V)] with a flow rate of 0.3 mL/min. Eluted molecules underwent positive electrospray ionization with ion spray capillary voltage at 2.80 kV, drying gas flow rate at 1000 L/h, and under a temperature of 650°C. Analysis was performed in MRM mode using three to four transitions per peptide. MRM parameters for the absolute quantification of proteins using SIL peptides method have been previously reported (Kamiie et al. 2008; Hoshi et al. 2013) (Table S1 ) and transitions for the cell markers can be found in Table S2 . Skyline (MacLean et al. 2010) software (version 3.1.0.7382) was used for MRM method development and peak integration. Further calculations and data analysis were performed using home-developed R scripts. Sample injection order was randomized using the RAND function from Excel software.
Statistical analysis
Statistical analysis was performed using R scripts. The peak areas and absolute values of the protein concentration were log2 transformed in order to take into account the data skewness and get a normal distribution (Mertens 2016) . Inter-day differences were assessed using one-way ANOVA, followed by t-test with Bonferroni's correction on the log2 transformed data (ANOVA and pairwise.t.test functions from stats package). The following data analyses were performed using the results from all the 12 samples, without sample exclusion.
Pearson correlation (rcorr function from Hmisc package) was applied to study the relationship between the different cell marker levels. Then, the correlation between the markers and the quantified transporters was calculated in order to evaluate the best fitting marker for normalization. Finally, the effect of normalizing the transporters' quantification against Pecam-1 was evaluated by dividing the absolute amounts by the peak area of peptide of Claudin-5, Glut-1, each Pecam-1 peptide, or the total area and differences between days were evaluated by t-test with Bonferroni's correction.
Results
Cell marker proteins detected by DDA in isolated cortical microvessels A total of 1640 proteins were identified from 8150 peptide matches, including 1178 proteins with at least two unique peptides. A detailed list of identified proteins and their identification scores can be found in Table S3 . Several cell markers of endothelial cells, pericytes, astrocytes, and neurons were detected in DDA; proteins routinely used as markers for these cells (Cahoy et al. 2008; Daneman et al. 2010; Zhang et al. 2014 ) are summarized in Table 1 . The transporter proteins P-gp, Bcrp, and three alpha subunits of the Na + /K + pump were also detected by DDA with high scores (Table 1) . The MASCOT protein score derives from the identification score for its peptides, which is calculated as À10log 10 (P), where P is the probability of detecting the peptides of the identified protein (higher score means higher certainty of the identification (Perkins et al. 1999) ; therefore it cannot be used directly to evaluate the amount of a protein, although proteins with higher concentrations often present high scores. Annotation of the whole protein list using DAVID Bioinformatics Tool (Huang et al. 2009a,b) (Figure S2 ) revealed that 85% of the proteins were annotated as intracellular proteins, 65% as intracellular membrane bounded organelles, and 26% as plasma membrane proteins.
MRM assay method development and refining for cell marker proteins and BSA Peptide detection by the LC-MS/MS and retention time (RT) were identified using unscheduled MRM methods to analyze the digested proteins of rat microvessels. Previous studies showed a high similarity in the fragment spectra obtained by mass spectrometers using higher energy collisional dissociation (HCD) for peptide fragmentation and triple-quadrupole MS with collision induced dissociation. In addition, the correlation between a spectral library obtained by HCD and the MRM relative intensity of the fragments, the dotp, was superior to 0.9. This suggests that HCD libraries are appropriate to define the transitions for MRM analysis (De Graaf et al. 2011) . All the validated peptides presented a good correlation of the transition relative intensity with the spectral library (dotp > 0.9). They were eluted within a 2-min window from the predicted retention time (Table S4 ) and presented high signal intensity (total peak height > 2 9 10 4 and total area > 2 9 10 5 ), except for YVGSQLASTSEVLK of Vwf (total peak height = 1.2 9 10 4 and total area = 8.3 9 10 4 ), which was still used because it was the only Vwf peptide with a dotp > 0.9. This is illustrated using Pecam-1 as an example in Figure S3 and a detailed report can be found in Table S4 . Three Pecam-1 peptides were validated, while for the other proteins only one peptide was validated. Some of these peptides have been previously used for protein quantification (Shawahna et al. 2011) .
The inter-injection reproducibility was evaluated by analyzing the three most intense Hi3 Ecoli â peptides added to the samples in the resuspension mix. These peptides presented a peak area %CV ≤ 17% between all samples analyzed ( Figure S4) ; showing that there is a low variability between injections and that comparisons could be performed without the need of heavy peptides, obtaining thus values in arbitrary units instead of fmol/lg of total protein. Stable isotope labeled quantification of ABC transporters and Na+/K+ ATPase The ABC transporters P-gp and Bcrp and the membrane marker protein Na + /K + ATPase isoform a (ATP1a) were quantified using SIL peptides and the results are summarized in Table 2 . In general, high variability was observed with coefficients of variation higher than 25% in some cases. The P-gp levels found on Day 3 were higher than on Day 2 (p < 0.01), while Bcrp was significantly higher at Day 3 than at Day 1 and Day 2 (p < 0.01). Nevertheless, the total Atp1a [peptide Atp1 a(1,2,3)] was significantly higher for Day 1 than the others (threefold). Interestingly, we observed differences in the isoform-specific levels of Atp1a. ATp1a1 and -a3 were similar between Day 2 and 3, but significantly lower than on Day 1 (p < 0.001), up to 3.4-fold for Atp1a1 and 6.6-fold for Atp1a3. Atp1a2 was slightly lower on Day 2 than on Day 3 (1.4-fold, p < 0.05), and both were significantly lower than Day 1 (up to 1.8-fold, p < 0.05).
Evaluation of the cell markers enrichment and BSA contamination The reproducibility of the microvessels isolation procedure was studied by the analysis of the cell marker proteins and BSA peptides without labeled peptides (Fig. 1) . All the peptides showed differences between the 3 days when tested using ANOVA, then a pair wise t-test with Bonferroni's The mean value of four samples is presented. Differences were tested with ANOVA followed by t-test with Bonferroni's correction. ns = nonsignificant, *< 0.05, **< 0.01, ***< 0.001. P-gp levels correspond to the mean of three peptides.
Fig. 1
Cell markers and bovine serum albumin (BSA) peak area (log2), ANOVA analyses revealed differences between the days for all the peptides, then differences were tested by a pairwise t-test using Bonferroni's correction after ANOVA: ns = non-significant, *p < 0.05, **p < 0.01, ***p < 0.001. In general, differences can be observed for the endothelial cell and astrocyte markers between Day 2 and Day 3, but not when Day 1 and 3 are compared. BSA contamination is significantly different between the 3 days and lower levels of cell markers are observed in the samples with higher levels of BSA contamination.
correction was applied to evaluate the inter-day differences. In general, most of the EC markers and all the astrocyte markers presented significant differences between Day 1 and Day 2, and between Day 2 and Day 3, but not when Day 1 and 3 were compared. The pericyte marker chondroitin sulfate proteoglycan Cspg4 (also called neural/glial antigen 2, Ng2) Nishiyama et al. (1995) showed no difference between any of the days. Regarding the EC markers, significant differences were observed between all the days for Basigin, between Day 2 and the other days for Claudin-5 and Glut-1, but no difference was observed for Vwf; while Pecam-1 was variable in function of the peptide. Importantly, BSA contamination was significantly different between the 3 days. In general, Day 2 presented the lowest amounts of cell marker peptides but the highest amounts of BSA, while on Day 3, the contrary was observed. Day 1 samples showed medium levels of BSA and slightly lower levels of cell markers than Day 3. The BSA amount was determined in each sample (n = 12) to study the impact of BSA on the protein quantification. The total quantities (lg) of BSA per 50 lg of total proteins are relatively low from 0.5 to 3.75 lg (mean = 1.9 lg, CV = 63.5%) and should not interfere with the protein quantification. In order to define the relationship between different cell marker levels, we studied the Pearson product-moment correlation coefficient (r) of the peptide peak areas (log2) and observed a positive correlation between the cell markers ( Figure S5 ).
Evaluation of the markers performance
We evaluated the suitability of using the different markers as normalization factors of protein quantification by calculating the Pearson correlation of the markers peak area (log2) against the calculated absolute amount (in log2) of P-gp, Bcrp, and Na + /K + ATPase (Fig. 2) peptides. Pearson product-moment correlation coefficient (r) was tested with 95% confidence level (N = 12, H 0 : r = 0). Pecam-1 was evaluated using either the area of each one of the three peptides alone (Pecam-1_p1, 2, and 3) or the sum of their peak areas (Pecam-1_total). The correlation with BSA was evaluated using the sum of the three peptides surveyed (BSA_total).
Correlation between cell markers levels and ABC transporters amount
The correlation coefficients (r) of the three P-gp peptides with a marker did not differ in more than 0.1 units; therefore results will be discussed for this protein in a global level instead of at the peptide level. P-gp and Bcrp levels were positively correlated with the peak area of almost all the markers. The correlation was moderate and non-significant for the endothelial cell marker Vwf (r ≤ 0.50) and moderate for Basigin (r = 0.54-0.684). P-gp presented high correlations with the endothelial cell markers Claudin-5, Glut-1, and Pecam-1_p1 (r = 0.79-0.92) and very high with Pecam1_p2 and p3, but also when the total area of Pecam-1 was used (r > 0.91). Bcrp correlation with these proteins was slightly lower but still significant (r > 0.74), and its correlation with the total area of Pecam-1 is high (r = 0.926). Both proteins presented a low and non-significant correlation with the pericytes marker Cspg4. Interestingly, the correlation with the astrocytes markers was moderate between Aqp4 and P-gp (r < 0.67) and for Bcrp (r = 0.608), but high between the two transporters and Gfap (r > 0.76).
Correlation between cell markers levels and the amount of membrane marker Na + /K + ATPase pump In general, the amount of Na + /K + ATPase subunit isoforms Atp1a1 and Atpa3 and the multi-specific peptide (a1/2/3) were not correlated with any of the cell markers or with BSA. Nevertheless, Atp1a2 presented a high correlation with the EC markers Basiginin (r = 0.884), Claudin-5 (r = 0.822), and Glut-1 (r = 0.774) and with the astrocyte marker Aqp4 (r = 0.84).
Normalization using Pecam-1, Claudin-5, and Glut-1 for proteins expressed by endothelial cells In order to evaluate the utilization of Pecam-1, Claudin-5, and Glut-1 as normalization factor for the evaluation of P-gp and Bcrp in brain microvessels samples, the absolute amounts (fmol/lg) were normalized by dividing the expression against the area of Claudin-5, Glut-1, and Pecam-1 peptides either individually or using the total peak area (Figs 3a and b) . Importantly, the variation between the microvessels isolated at each day (%CV) decreased in all the normalization approaches for both P-gp and Bcrp compared to the absolute values (Table 2) . P-gp levels are significantly different between Day 1 and 3 (p = 2.55 9 10
À2
) and between Day 2 and 3 (p = 5 9 10 À4 ) when Pecam-1_p1 is used and between Day 2 and 3 using Pecam-1_p3 (p = 4.6 9 10
), but not when using Pecam-1_p2 and Pecam-1_total (Fig. 3a) . If Glut-1 and Claudin-5 (Fig. 3b) were used for normalization, a higher level could be observed on Day 2 for P-gp, which was not observed when Pecam-1 was used for normalization; although the non-normalized expression on Day 2 was in fact lower than on Day 1 and Day 3 (Table 2) .
After normalization, Bcrp showed significantly different levels between Day 3 and the other two experiments, which was not observed when the absolute values were used.
Discussion
Cell marker proteins detected by DDA in isolated cortical microvessels Twenty-six percent of the proteins identified by DDA ( Figure S2 ) were annotated as plasma membrane, indicating a good representation of this type of proteins. Fig. 2 Pearson correlation between the cell marker protein levels (yaxis, log2) and the absolute levels (x-axis, log2) of the proteins of interest quantified by the absolute quantification of proteins using stable isotope labeled peptides approach (x-axis, log2). Significant correlations are signaled (confidence = 95%, N = 12): *p < 0.05, **p < 0.01, ***p < 0.001. In general, P-gp and Bcrp presented a positive significant correlation with the endothelial cell markers and astrocyte markers, but not with the pericyte marker Cspg4. On the contrary, they showed a negative correlation with the contaminant bovine serum albumin (BSA). In most cases, there is no correlation between the Atp1a isoforms and cell markers. Fig. 3 P-gp and Bcrp levels in rat cortical microvessels in the 3 days of experiments normalized to (a) Pecam-1 (individual peptides and total peak area), (b) claudin-5, and Glut-1. Horizontal bars correspond to the mean of four samples. ANOVA analyses revealed differences between the days for all the peptides, then differences were tested by a pairwise t-test using Bonferroni's correction after ANOVA: ns = non-significant, *p < 0.05, **p < 0.01, ***p < 0.001. Coefficients of variation (%CV) are presented under each plot. The variability between the microvessels isolated at each day (%CV) decreased in all the normalization approaches for both P-gp and Bcrp compared to the absolute values.
The presence of endothelial cells, pericytes, astrocytes, and neurons in the brain microvessel samples was confirmed by the detection of several previously reported marker proteins (Table 1) of each cellular phenotype (Cahoy et al. 2008; Daneman et al. 2010; Shawahna et al. 2011; Zhang et al. 2014) . Contaminant BSA was detected within the top 20 proteins with the highest identification score (Tables 1 and  S3) , indicating thus a high certainty of its presence in the samples. However, BSA should not interfere with the protein quantification because of its low amount in sample (average value 3.8% (w/w).
Although it has been previously shown by RT-qPCR that they are mostly eliminated during microvessels isolation (Yousif et al. 2007 ), neurons and oligodendrocyte protein markers were detected by DDA analysis (Tables 1 and S3 ), indicating the presence of remnants of these cells. Some of the markers were identified with high score, like the neuron marker Tubulin beta-3 chain (score = 2128) and the oligodendrocyte marker 2 0 ,3 0 -cyclic-nucleotide 3 0 -phosphodiesterase (score = 844), but, this score cannot allow us to estimate the levels of these proteins in the sample or the proportion of these cells in the samples. In the study, we focused on endothelial cell markers and therefore neuron and oligodendrocyte markers were not included in the MRM method.
P-gp (Abcb1) and Bcrp (Abcg2) were detected in the DDA experiment (Tables 1 and S3 ). Although these proteins are well known to be expressed in brain microvessels (Yousif et al. 2007; Hoshi et al. 2013; Chaves et al. 2014) , this further confirms their presence in our samples. Similarly, the Na + /K + ATPase a1, a2, and a3 isoforms (Atp1a1, 2, 3) were also identified but a4 was not detected. This coincides with the Na + /K + ATPase alpha isoforms previously detected in the BBB (reviewed in Blanco and Mercer 1998) . Other significant transporters in neuropsychopharmacology were detected in the DDA experiment (Table S3) , including several members of the solute carrier transporters superfamily such as Oat3 which contributes to the efflux of dopamine metabolites including uremic toxins and some drugs (Ohtsuki et al. 2002; Mori et al. 2004) . Nevertheless, the study of these proteins was not part of our study and they were not included in the analysis for practical reasons (i.e., multiplexing analysis limitations).
Sample heterogeneity revealed by quantification of ABC transporters and Na + /K + ATPase
The protein amounts (Table 2 ) of P-gp and Bcrp and the membrane marker protein Na + /K + ATPase isoform a (ATP1a) were in levels of similar order of magnitude than previously reported results using similar methods for the study of rat brain microvessels . P-gp was found in higher levels than Bcrp in all the samples, up to 20-fold in a molecular basis. Bcrp forms homodimers to become functional, therefore the difference in functional protein can be even greater.
Differences in total Atp1a (multi-isoform peptide) indicate possible discrepancies either because of the isolation and protein extraction or biological differences between the rat groups. Furthermore, differences in the Atp1a isoforms proportion between the days could indicate heterogeneity in the cell composition of the microvessel samples because the Atp1a isoforms are differentially expressed in the parenchymal cells; nevertheless, the Atp1a isoforms do not allow us to finely evaluate the enrichment on ECs. Indeed, the Atp1a isoform is known to be ubiquitous, including all the parenchymal cells, while -a2 and -a3 isoforms' expression is cell dependent (reviewed in Blanco and Mercer 1998) . Neurons may express different Atp1a isoforms depending on their function and location, although it has been observed by immunostaining in rat cortex samples (McGrail et al. 1991) and by RNA-sequencing using mouse cortical brain isolated cells (Zhang et al. 2014 ) that cortical neurons express Atp1a1 and Atp1a3 isoforms, while astrocytes express Atpa1 and Atp1a2. The RNA-sequencing results from Zhang et al. (2014) also showed that mouse brain endothelial cells express mostly Atp1a1 and probably Atp1a2 in very low amounts, but this has not been verified by immunostaining.
It has been previously observed that microvessels obtained by mechanical isolation contain a heterogenous mix of endothelial cells, pericytes, astrocyte feet, and other cell fragments, as indicated with the detection of several cell markers (Pardridge 1999; Dauchy et al. 2008; Chun et al. 2011; Shawahna et al. 2011) .
Differences in the levels of proteins and the high variability observed may be because of biological differences and/or the heterogeneity in the samples as a result of intraday and inter-day variability in microvessel extraction and/or biological differences but not to the sample treatment because these steps are controlled by an external protein added before the protein precipitation and digestion (GomezZepeda et al. 2016) .
This heterogeneity can contribute to a misinterpretation of the results in the molecular characterization of the bloodbrain barrier and bias in protein quantification. We thus suggest that sample heterogeneity should be carefully studied when similar methods are used.
Evaluation of the markers performance Microvessels used in this work were extracted at different times and on different days. Therefore, we considered that normalization against one or more cellular markers could be used to account for cell heterogeneity of samples.
Correlation between cell markers levels and ABC transporters amount The endothelial cell marker Vwf (Sadler J. E. 1998) could be partially lost during the sample treatment and this may also be the case of Basigin, an extracellular matrix metalloproteinase inducer. This explains the low Pearson correlation observed in Fig. 2 between these cell markers and the quantified membrane proteins; which indicates that they should not be used for the normalization of other proteins expressed in endothelial cells. P-gp is expressed at the brain almost uniquely in the microvessels' endothelial cells (Yousif et al. 2007; Hartz and Bauer 2011) . P-gp is expressed in the brain mainly in the microvessels' endothelial cells of healthy rats (Yousif et al. 2007; Hartz and Bauer 2011) . P-gp was found in primary cultures of astrocyte in the rat and in vivo studies showed that P-gp may also co-localize with Gfap in rat and monkey brain slices at astrocyte foot processes that are embedded in the abluminal membranes of endothelial cells (Golden and Pardridge 1999; Decl eves et al. 2000; Mercier et al. 2004; Ronaldson et al. 2004) . However, using recently confocal immunofluorescence, we did not co-localize P-gp with Gfap in rat brain slices (Saubam ea et al. 2012) . Moreover, a very recent study on the transcriptome and translatome of astrocyte foot processes using mice brain microvessels isolation developed in our laboratory, did not evidence any mRNA and protein expression of P-gp in astrocyte endfeets (Boulay et al. 2017) . Therefore, we cannot exclude that weak amounts of astrocyte foot P-gp in isolated rat brain microvessels may contaminate whole P-gp expression in our study and it seems unlikely.
Consequently, it was expected to find a high correlation with the levels of its specific markers, as it was observed for Claudin-5, Glut-1, and Pecam-1 (Fig. 2) . Therefore, the latter, good markers of ECs can be used for the normalization of MRM quantification data for proteins expressed in these cells.
Bcrp presented slightly lower correlation levels to the EC markers than P-gp despite being expressed in these cells, but this could be because Bcrp can also be expressed in pericytes and astrocytes (Eisenbl€ atter et al. 2003; Lee et al. 2007) . Therefore, the total amount of Bcrp quantified may be originated from the three different cells. We expected to observe a moderate correlation (Fig. 2) between the levels of P-gp and Bcrp against astrocyte feet and pericyte markers because these cells are coisolated with the endothelial cells during the mechanical procedure. Nevertheless, it is interesting that the astrocyte membrane marker Aqp4 showed a lower correlation than the cytosolic protein Gfap.
Correlation between cell markers levels and the amount of membrane marker Na + /K + ATPase pump The lack of correlation between Na + /K + ATPase a-subunit isoforms and other cell markers may be because of the expression of each isoform in different cells, especially for ubiquitous isoform Atp1a1 (Blanco and Mercer 1998) . Nevertheless, the good correlation of Atp1a2 markers with astrocyte markers could be because of its high expression in these cells relatively to the other cells of the neurovascular unit, as it has been observed by RNA-sequencing in isolated cells from mouse brain cortex (Zhang et al. 2014) .
Normalization using Pecam-1, Claudin-5, and Glut-1 for proteins expressed by endothelial cells The decrease in variability between samples (Fig. 3) was expected since the normalization takes into account the sample heterogeneity. Interestingly, different effects can be observed depending on the peptide used for normalization, which could be because of analytical variations (i.e., their detection in LC-MS/MS). The significant differences that appeared when using Claudin-5, Glut-1, Pecam-1_p1, and Pecam-1_p3 for normalization indicate that using these peptides alone may not be suitable for normalization. Moreover, a higher level can be observed on Day 2 when Claudine-5 and Glut-1 were used for normalization, which was not observed with Pecam-1 although non-normalized expression on Day 2 was in fact lower than on Day 1 and Day 3. Even though we cannot conclude if this effect was as a result of differences in the samples, such a contradictory effect because of normalization is not desired.
We consider that using the total peak area from the three peptides should be preferred in order to take better into account any variability, while increasing the certainty of the result. Actually, it is advised to use three peptides eluting in different times for the quantification normalization in order to consider the fluctuations during the LC gradient (Silva et al. 2006) . It is the case for Pecam-1_total. Therefore, we cannot conclude that Glut-1 or Claudin-5 should not be used for the normalization of P-gp expression because we used only one peptide of each of these proteins.
After normalization, Bcrp showed significantly different levels between Day 3 and the other two experiments, which was not observed when the absolute values are used. This can be because of biological differences as it is fourfold higher on Day 3 than on Day 1 and 2, which are not detected as significant changes without normalization due to the high variability in the Bcrp determination (CV% 29.8-46.9, Table 2 ), but these differences could also be as a result of heterogeneity in the cell composition of the sample. Nevertheless, Pecam-1, Glut-1, and Claudin-5 are probably not the best markers to be used for the normalization of Bcrp as this transporter is not only expressed in the ECs but also in the astrocytes and pericytes. Moreover, a high positive correlation can be observed between P-gp and Bcrp in all cases, with a significant Pearson productmoment correlation coefficient (r) of 0.85-0.90. Considering the expression of P-gp and Bcrp in BECs, this is not surprising.
Together with the high correlation between Pecam-1 and the other membrane markers of the endothelial cells, the normalization results indicate that this normalization procedure can be used to take into account the enrichment of endothelial cells for the comparison of P-gp levels between samples, although its use for Bcrp should be further studied. However, if Pecam-1 is modified during comparative study, it cannot be used for P-gp normalization. The evaluation of normalization by Glut-1 and Claudin-5 should be further studied using three peptides of these proteins, to consider fluctuations during the LC gradient (Silva et al. 2006) .
In addition, a similar strategy could be used to evaluate the contamination of other kind of samples (e.g., cells cultured in media containing animal serum) by non-endogenous proteins but also to find specific cell markers for quantification normalization.
In this paper, we described the unlabeled MRM method used to evaluate the levels of endothelial cells, pericyte, and astrocyte markers in the rat brain cortical microvessels and so the cell heterogeneity. Consequently, the quantification of endogenous proteins can be impacted by these contaminants which could induce bias in results and interpretation. The normalization of quantification of endothelial cell proteins is the best when we use the area of three peptides of EC marker obtained by targeted LC-MS/MS. This normalization could be used in comparative analysis, for instance in different treatment conditions or when species are to be compared.
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